« Back
Immatics Webcast - Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
Nov 08 - Nov 09, 2023
The webcast and presentation can be accessed directly through this link.
Participants may also access the slides presented in the webcast on the Immatics website in the Investors section under “Presentations” at www.investors.immatics.com/events-presentations.
Read the full report here: Press Release.